{"title":"感染不同类型幽门螺杆菌对胃分泌功能的影响:一项横断面临床研究","authors":"Jinglei Wang, Dehong Qiao, Yunzhu Wang, Rui Xiong, Xinyi Ding, Wei Zhang, Tingting Wang, Kai Tang","doi":"10.2147/IJGM.S477480","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Helicobacter pylori (Hp)-related gastropathies are accompanied by alterations in gastric secretion function, but the effects of infection of different Hp strains on gastric function are not yet well-elucidated. Our cross-sectional clinical study aim to research the effects of infection with different Hp types on gastric function.</p><p><strong>Patients and methods: </strong>We analyzed 525 patients' serum cytotoxin-associated protein gene A (CagA), vacuolating cytotoxin-associated protein gene A (VacA), urease (Ure), Gastrin-17 (G-17), Pepsinogen I (PGI), Pepsinogen II (PGII) and PGI/PGII ratio (PGR).</p><p><strong>Results: </strong>The PGII levels (8.19 ± 5.44 <i>vs</i> 5.98 ± 10.75, <i>P</i> = 0.013) were higher in the Hp infected group than in the uninfected, while the PGR levels (16.81 ± 8.22 <i>vs</i> 23.23 ± 8.36, <i>P</i> < 0.001) were lower. The PGR levels were higher in the uninfected group (23.23 ± 8.36, <i>P</i> < 0.001) than in Hp-I (16.47 ± 7.45) and Hp-II infected groups (17.39 ± 8.98). In the uninfected group, the G-17 level was positively correlated with the levels of PGI (Pearson coefficient = 0.177, <i>P</i> = 0.001), PGII (Pearson coefficient = 0.140, <i>P</i> = 0.008) and age (Pearson coefficient = 0.121, <i>P</i> = 0.022), negatively with the PGR levels (Pearson coefficient = -0.201, <i>P</i> < 0.001). In the Hp-I (Pearson coefficient = -0.003, <i>P</i> = 0.975) and Hp-II (Pearson coefficient = 0.018, <i>P</i> = 0.161) infected groups, the G-17 levels were not correlated with age.</p><p><strong>Conclusion: </strong>Hp-I with CagA and/or VacA positive and Hp-II without cytotoxicity can reduce gastric secretion function regardless of age and sex. Gastric function in patients with Hp eradication was similar to that in those without Hp infection. G-17 rises physiologically with age, but infection with Hp will affect it.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11471097/pdf/","citationCount":"0","resultStr":"{\"title\":\"Effects of Infection with Different Types of <i>Helicobacter pylori</i> on Gastric Secretion Function: A Cross-Sectional Clinical Study.\",\"authors\":\"Jinglei Wang, Dehong Qiao, Yunzhu Wang, Rui Xiong, Xinyi Ding, Wei Zhang, Tingting Wang, Kai Tang\",\"doi\":\"10.2147/IJGM.S477480\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Helicobacter pylori (Hp)-related gastropathies are accompanied by alterations in gastric secretion function, but the effects of infection of different Hp strains on gastric function are not yet well-elucidated. Our cross-sectional clinical study aim to research the effects of infection with different Hp types on gastric function.</p><p><strong>Patients and methods: </strong>We analyzed 525 patients' serum cytotoxin-associated protein gene A (CagA), vacuolating cytotoxin-associated protein gene A (VacA), urease (Ure), Gastrin-17 (G-17), Pepsinogen I (PGI), Pepsinogen II (PGII) and PGI/PGII ratio (PGR).</p><p><strong>Results: </strong>The PGII levels (8.19 ± 5.44 <i>vs</i> 5.98 ± 10.75, <i>P</i> = 0.013) were higher in the Hp infected group than in the uninfected, while the PGR levels (16.81 ± 8.22 <i>vs</i> 23.23 ± 8.36, <i>P</i> < 0.001) were lower. The PGR levels were higher in the uninfected group (23.23 ± 8.36, <i>P</i> < 0.001) than in Hp-I (16.47 ± 7.45) and Hp-II infected groups (17.39 ± 8.98). In the uninfected group, the G-17 level was positively correlated with the levels of PGI (Pearson coefficient = 0.177, <i>P</i> = 0.001), PGII (Pearson coefficient = 0.140, <i>P</i> = 0.008) and age (Pearson coefficient = 0.121, <i>P</i> = 0.022), negatively with the PGR levels (Pearson coefficient = -0.201, <i>P</i> < 0.001). In the Hp-I (Pearson coefficient = -0.003, <i>P</i> = 0.975) and Hp-II (Pearson coefficient = 0.018, <i>P</i> = 0.161) infected groups, the G-17 levels were not correlated with age.</p><p><strong>Conclusion: </strong>Hp-I with CagA and/or VacA positive and Hp-II without cytotoxicity can reduce gastric secretion function regardless of age and sex. Gastric function in patients with Hp eradication was similar to that in those without Hp infection. G-17 rises physiologically with age, but infection with Hp will affect it.</p>\",\"PeriodicalId\":14131,\"journal\":{\"name\":\"International Journal of General Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2024-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11471097/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of General Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/IJGM.S477480\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of General Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJGM.S477480","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Effects of Infection with Different Types of Helicobacter pylori on Gastric Secretion Function: A Cross-Sectional Clinical Study.
Purpose: Helicobacter pylori (Hp)-related gastropathies are accompanied by alterations in gastric secretion function, but the effects of infection of different Hp strains on gastric function are not yet well-elucidated. Our cross-sectional clinical study aim to research the effects of infection with different Hp types on gastric function.
Patients and methods: We analyzed 525 patients' serum cytotoxin-associated protein gene A (CagA), vacuolating cytotoxin-associated protein gene A (VacA), urease (Ure), Gastrin-17 (G-17), Pepsinogen I (PGI), Pepsinogen II (PGII) and PGI/PGII ratio (PGR).
Results: The PGII levels (8.19 ± 5.44 vs 5.98 ± 10.75, P = 0.013) were higher in the Hp infected group than in the uninfected, while the PGR levels (16.81 ± 8.22 vs 23.23 ± 8.36, P < 0.001) were lower. The PGR levels were higher in the uninfected group (23.23 ± 8.36, P < 0.001) than in Hp-I (16.47 ± 7.45) and Hp-II infected groups (17.39 ± 8.98). In the uninfected group, the G-17 level was positively correlated with the levels of PGI (Pearson coefficient = 0.177, P = 0.001), PGII (Pearson coefficient = 0.140, P = 0.008) and age (Pearson coefficient = 0.121, P = 0.022), negatively with the PGR levels (Pearson coefficient = -0.201, P < 0.001). In the Hp-I (Pearson coefficient = -0.003, P = 0.975) and Hp-II (Pearson coefficient = 0.018, P = 0.161) infected groups, the G-17 levels were not correlated with age.
Conclusion: Hp-I with CagA and/or VacA positive and Hp-II without cytotoxicity can reduce gastric secretion function regardless of age and sex. Gastric function in patients with Hp eradication was similar to that in those without Hp infection. G-17 rises physiologically with age, but infection with Hp will affect it.
期刊介绍:
The International Journal of General Medicine is an international, peer-reviewed, open access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treatment protocols. The journal is characterized by the rapid reporting of reviews, original research and clinical studies across all disease areas.
A key focus of the journal is the elucidation of disease processes and management protocols resulting in improved outcomes for the patient. Patient perspectives such as satisfaction, quality of life, health literacy and communication and their role in developing new healthcare programs and optimizing clinical outcomes are major areas of interest for the journal.
As of 1st April 2019, the International Journal of General Medicine will no longer consider meta-analyses for publication.